These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18607579)

  • 1. Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate.
    Kang W; Kim K; Kim EY; Kwon KI; Bang JS; Yoon YR
    Eur J Clin Pharmacol; 2008 Oct; 64(10):1027-30. PubMed ID: 18607579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of pH to systemic exposure of niflumic acid following oral administration of talniflumate.
    Kim E; Kang W
    Eur J Clin Pharmacol; 2011 Apr; 67(4):425-428. PubMed ID: 21327911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography.
    Jang DJ; Park JS; Ko HR; Jee JP; Kim JK; Kim ST; Kim CK
    Biomed Chromatogr; 2005 Jan; 19(1):32-5. PubMed ID: 15470687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic comparison of two formulations of talniflumate 370 mg tablets in healthy Korean volunteers
.
    Kim Y; Yim S; Kim BH; Lee S
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):102-108. PubMed ID: 27879193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of talniflumate and niflumic acid in human plasma by liquid chromatography-tandem mass spectrometry.
    Kang W; Kim K
    Anal Sci; 2009 Apr; 25(4):571-4. PubMed ID: 19359802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-mass spectrometric method for the sensitive determination of niflumic acid in human plasma and its application to pharmacokinetic study of talniflumate tablet.
    Park EJ; Na DH; Shin YH; Lee KC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):159-62. PubMed ID: 19010744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Differential Food Patterns on the Pharmacokinetics of Enteric-Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese Volunteers.
    Zhang SH; Li Y; Wei SS; Guo L; Huang XM; Chen Y; Wu XX; Cai HL; Zhang BK
    Clin Pharmacol Drug Dev; 2020 Jan; 9(1):41-49. PubMed ID: 31056855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of niflumic acid in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection and its application to a bioequivalence study of talniflumate tablets.
    Lee HW; Won KJ; Cho SH; Ha YH; Park WS; Yim HT; Baek M; Rew JH; Yoon SH; Yim SV; Chung JH; Lee KT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(2):215-20. PubMed ID: 15921965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol.
    Carsenti-Etesse H; Farinotti R; Durant J; Roger PM; De Salvador F; Bernard E; Rouveix B; Dellamonica P
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):357-66. PubMed ID: 9842977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
    Lin TY; Yang MH; Chang FY
    Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dose timing in relation to food intake on systemic exposure to blonanserin.
    Saruwatari J; Yasui-Furukori N; Inoue Y; Kaneko S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):899-902. PubMed ID: 20490472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers.
    Lu C; Jia Y; Chen L; Ding Y; Yang J; Chen M; Song Y; Sun X; Wen A
    J Clin Pharm Ther; 2013 Apr; 38(2):136-40. PubMed ID: 23278367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary fat content in meals on pharmacokinetics of quazepam.
    Yasui-Furukori N; Kondo T; Takahata T; Mihara K; Ono S; Kaneko S; Tateishi T
    J Clin Pharmacol; 2002 Dec; 42(12):1335-40. PubMed ID: 12463728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of food on the bioavailability of palbociclib.
    Ruiz-Garcia A; Plotka A; O'Gorman M; Wang DD
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):527-533. PubMed ID: 28204912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
    Desjardins PJ; Olugemo K; Solorio D; Young CL
    Clin Ther; 2015 Feb; 37(2):448-61. PubMed ID: 25499666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
    Kinzler ER; Pantaleon C; Iverson M; Aigner S
    Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the non-steroidal anti-inflammatory drug niflumic acid in humans: a combined 19F-MRS in vivo and in vitro study.
    Bilecen D; Schulte AC; Kaspar A; Küstermann E; Seelig J; Elverfeldt D; Scheffler K
    NMR Biomed; 2003 May; 16(3):144-51. PubMed ID: 12884358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
    Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
    Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.